Published in Med Pediatr Oncol on July 01, 1997
Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years. Pediatr Blood Cancer (2012) 1.60
Clinicopathological features and BRAF(V600E) mutations in patients with isolated hypothalamic-pituitary Langerhans cell histiocytosis. Diagn Pathol (2016) 0.75
The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues. Mol Cell Biol (1989) 2.35
Localized expression of the atrial natriuretic factor gene during cardiac embryogenesis. Genes Dev (1987) 2.24
The multidrug resistance (mdr1) gene product functions as an ATP channel. Proc Natl Acad Sci U S A (1993) 2.09
Advantage of protons compared to conventional X-ray or IMRT in the treatment of a pediatric patient with medulloblastoma. Int J Radiat Oncol Biol Phys (2004) 2.00
Cognitive sequelae in children treated for acute lymphoblastic leukemia with dexamethasone or prednisone. J Pediatr Hematol Oncol (2000) 1.93
Intensified therapy for infants with acute lymphoblastic leukemia: results from the Dana-Farber Cancer Institute Consortium. Cancer (1997) 1.82
Craniopharyngiomas in children. Long-term effects of conservative surgical procedures combined with radiation therapy. J Neurosurg (1990) 1.76
20-year experience in childhood craniopharyngioma. Int J Radiat Oncol Biol Phys (1993) 1.75
Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease. Cancer J Sci Am (2006) 1.70
Second malignancies in patients treated for childhood acute lymphoblastic leukemia. J Clin Oncol (1998) 1.63
Adult medulloblastoma: prognostic factors and patterns of relapse. Neurosurgery (2000) 1.49
Childhood soft tissue sarcoma: a 20-year experience. J Pediatr (1997) 1.44
Clinical significance of P-glycoprotein in multidrug resistance malignancies. Blood (1993) 1.43
Stereotactic radiotherapy for pediatric and adult brain tumors: preliminary report. Int J Radiat Oncol Biol Phys (1994) 1.43
Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia. N Engl J Med (1986) 1.42
Prognostic factors for patients with Hodgkin disease in first relapse. Cancer (1993) 1.42
Moyamoya following cranial irradiation for primary brain tumors in children. Neurology (2007) 1.40
Long-term results of children with acute myeloid leukemia: a report of three consecutive Phase III trials by the Children's Cancer Group: CCG 251, CCG 213 and CCG 2891. Leukemia (2005) 1.40
Cognitive sequelae of treatment in childhood acute lymphoblastic leukemia: cranial radiation requires an accomplice. J Clin Oncol (1995) 1.39
Non-P-glycoprotein mediated mechanism for multidrug resistance precedes P-glycoprotein expression during in vitro selection for doxorubicin resistance in a human lung cancer cell line. Cancer Res (1990) 1.39
Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber Cancer Institute/Children's Hospital Acute Lymphoblastic Leukemia Consortium Protocol 85-01. J Clin Oncol (1994) 1.27
Clinical relevance of transmembrane drug efflux as a mechanism of multidrug resistance. J Clin Oncol (1998) 1.26
Cloning and characterization of allograft inflammatory factor-1: a novel macrophage factor identified in rat cardiac allografts with chronic rejection. J Clin Invest (1995) 1.23
Absence of colony-stimulating factor-1 in osteopetrotic (csfmop/csfmop) mice results in male fertility defects. Biol Reprod (1996) 1.20
The relationship of sex and treatment modality to neuropsychologic outcome in childhood acute lymphoblastic leukemia. J Clin Oncol (1992) 1.19
Progesterone interacts with P-glycoprotein in multidrug-resistant cells and in the endometrium of gravid uterus. J Biol Chem (1989) 1.18
Biology of Langerhans cells and Langerhans cell histiocytosis. Int Rev Cytol (2006) 1.17
Hemorrhagic vasculopathy after treatment of central nervous system neoplasia in childhood: diagnosis and follow-up. AJNR Am J Neuroradiol (1995) 1.15
Nonrandom chromosomal gains in pilocytic astrocytomas of childhood. Hum Pathol (1995) 1.15
Allelotype of pediatric rhabdomyosarcoma. Oncogene (1997) 1.13
STAT3 activation is required for Asp(816) mutant c-Kit induced tumorigenicity. Oncogene (2001) 1.12
Pneumococcal conjugate vaccine primes for antibody responses to polysaccharide pneumococcal vaccine after treatment of Hodgkin's disease. J Infect Dis (1996) 1.10
Proliferation-associated SNF2-like gene (PASG): a SNF2 family member altered in leukemia. Cancer Res (2000) 1.07
Neurological dysfunction associated with postoperative cerebellar mutism. J Neurooncol (2000) 1.06
The prognostic significance of postoperative residual tumor in ependymoma. Neurosurgery (1991) 1.04
Binding properties of monoclonal antibodies recognizing external epitopes of the human MDR1 P-glycoprotein. Int J Cancer (1993) 1.04
Eosinophilic granuloma of the clivus: case report, follow-up of two previously reported cases, and review of the literature on cranial base eosinophilic granuloma. Neurosurgery (1997) 1.04
Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome. Blood (1996) 1.04
Diencephalic syndrome: clinical features and imaging findings. AJNR Am J Neuroradiol (1997) 1.03
Histone variants and chromatin structure during sea urchin development. Dev Biol (1980) 1.03
Malignant small round cell tumor (Ewing's-PNET) of the chest wall in children. J Pediatr Surg (1994) 1.03
Activation of neurotrophin-3 receptor TrkC induces apoptosis in medulloblastomas. Cancer Res (1999) 1.02
The programmed switch in lysine-rich histone synthesis at gastrulation. Cell (1976) 1.01
Late effects of central nervous system treatment of acute lymphoblastic leukemia in childhood are sex-dependent. Dev Med Child Neurol (1990) 1.00
Magnetic resonance imaging changes after stereotactic radiation therapy for childhood low grade astrocytoma. Cancer (1996) 1.00
mdr2 encodes P-glycoprotein expressed in the bile canalicular membrane as determined by isoform-specific antibodies. J Biol Chem (1992) 0.98
Definitive radiation therapy in the management of symptomatic patients with optic glioma. Survival and long-term effects. Cancer (1990) 0.98
Adaptation and verification of the relocatable Gill-Thomas-Cosman frame in stereotactic radiotherapy. Int J Radiat Oncol Biol Phys (1994) 0.97
Congenital and neonatal leukemia. Semin Perinatol (1999) 0.97
Low-dose versus high-dose methotrexate during remission induction in childhood acute lymphoblastic leukemia (Protocol 81-01 update). Blood (1991) 0.96
Medulloblastoma at the joint center for radiation therapy between 1968 and 1984. The influence of radiation dose on the patterns of failure and survival. Cancer (1988) 0.95
Identification and upregulation of galactose/N-acetylgalactosamine macrophage lectin in rat cardiac allografts with arteriosclerosis. J Clin Invest (1994) 0.95
Memory deficits among children with craniopharyngiomas. Neurosurgery (2001) 0.95
Allograft inflammatory factory-1. A cytokine-responsive macrophage molecule expressed in transplanted human hearts. Transplantation (1996) 0.93
Stereotactic techniques in managing pediatric brain tumors. Childs Nerv Syst (1993) 0.93
Ewing sarcoma of the rib: results of an intergroup study with analysis of outcome by timing of resection. J Thorac Cardiovasc Surg (2000) 0.92
Brain tumors after cranial irradiation for childhood acute lymphoblastic leukemia. A 13-year experience from the Dana-Farber Cancer Institute and the Children's Hospital. Cancer (1987) 0.92
Primary lymphoma of bone in children: analysis of treatment results with adriamycin, prednisone, Oncovin (APO), and local radiation therapy. J Clin Oncol (1986) 0.92
An SNF2 factor involved in mammalian development and cellular proliferation. Dev Dyn (2001) 0.91
Syngeneic and allogeneic bone marrow engraftment after total body irradiation: dependence on dose, dose rate, and fractionation. Blood (1991) 0.91
Activating mutations of c-kit at codon 816 confer drug resistance in human leukemia cells. Leuk Lymphoma (2001) 0.90
Stage IA-IIB Hodgkin's disease: management and outcome of extensive thoracic involvement. Int J Radiat Oncol Biol Phys (1997) 0.90
CT quantitation of tracheal cross-sectional area as a guide to the surgical and anesthetic management of children with anterior mediastinal masses. J Pediatr Surg (1991) 0.90
Bone marrow transplantation for children with myelodysplastic syndromes. Blood (1989) 0.90
Clinical presentation and outcome in lymphocyte-predominant Hodgkin's disease. J Clin Oncol (1997) 0.89
Sex differences in cognitive processing in children treated with CNS prophylaxis for acute lymphoblastic leukemia. J Pediatr Psychol (1990) 0.89
Sea urchin sperm chromatin structure as probed by pancreatic DNase I: evidence for a noval cutting periodicity. Dev Biol (1980) 0.89
Results of radiosurgery in the management of recurrent and residual medulloblastoma. Pediatr Neurosurg (1995) 0.89
Surgery, radiation, and combination therapy in the treatment of childhood craniopharyngioma--a 20-year experience. Pediatr Neurosurg (1994) 0.88
Hypertension in long-term survivors of childhood renal cancers. J Clin Oncol (1989) 0.88
Chest wall tumors in infancy and childhood. Cancer (1989) 0.88
Toxicity of CNS prophylaxis for childhood leukemia. Oncology (Williston Park) (1997) 0.87
Correction of autoimmune lymphoproliferative syndrome by bone marrow transplantation. Bone Marrow Transplant (1998) 0.87
Noncoincidence of histone and DNA synthesis in cleavage cycles of early development. Proc Natl Acad Sci U S A (1977) 0.87
Expression and ontogeny of murine CD2. Eur J Immunol (1989) 0.87
Heterozygous germline ATM mutations do not contribute to radiation-associated malignancies after Hodgkin's disease. J Clin Oncol (1999) 0.87
Seizures in children with supratentorial astroglial neoplasms. Pediatr Neurosurg (1994) 0.87
Intracranial germinoma: the case for lower dose radiation therapy. Int J Radiat Oncol Biol Phys (1997) 0.86
Irradiated B7-1 transduced primary acute myelogenous leukemia (AML) cells can be used as therapeutic vaccines in murine AML. Blood (1996) 0.86
Prognostic factors in medulloblastoma, including DNA ploidy. J Clin Oncol (1993) 0.85
Fractionation and dose rate effects in mice: a model for bone marrow transplantation in man. Int J Radiat Oncol Biol Phys (1987) 0.85
Role of colony stimulating factor-1 (CSF-1) and other lympho-hematopoietic growth factors in mouse pre-implantation development. Bioessays (1991) 0.85
Image fusion for stereotactic radiotherapy and radiosurgery treatment planning. Int J Radiat Oncol Biol Phys (1994) 0.85
Induction of embryonic vasculogenesis by bFGF and LIF in vitro and in vivo. Dev Biol (1996) 0.85
A 10-year experience of pediatric brachytherapy. Int J Radiat Oncol Biol Phys (1995) 0.84
Intravascular hemolysis and renal insufficiency after bone marrow transplantation. Blood (1988) 0.84
Anti-B4-blocked ricin synergizes with doxorubicin and etoposide on multidrug-resistant and drug-sensitive tumors. Blood (1995) 0.84
Paratesticular rhabdomyosarcoma: results of therapy in 18 cases. J Urol (1990) 0.84
Ototoxicity of preradiation cisplatin for children with central nervous system tumors. J Clin Oncol (1990) 0.84
Childhood optic chiasm gliomas: radiographic response following radiotherapy and long-term clinical outcome. Int J Radiat Oncol Biol Phys (1997) 0.83
Radiosurgery in the management of pediatric brain tumors. Int J Radiat Oncol Biol Phys (2001) 0.83
Interactions of steroid, methotrexate, and radiation determine neurotoxicity in an animal model to study therapy for childhood leukemia. Pediatr Res (1994) 0.83
The oral health of long-term survivors of acute lymphoblastic leukaemia: a comparison of three treatment modalities. Eur J Cancer B Oral Oncol (1995) 0.83
Anesthesia for stereotactic radiosurgery in children. J Neurosurg Anesthesiol (1995) 0.83
A stereotactic radiation therapy device for retinoblastoma using a noncircular collimator and intensity filter. Med Phys (1998) 0.82
The development of Graves' disease following radiation therapy in Hodgkin's disease. Int J Radiat Oncol Biol Phys (1988) 0.82